Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Hypertension V: Nursing Management

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Antihypertensive Drugs: Direct Renin Inhibitors

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emotion regulation in mother-child dyads is associated with interbrain synchrony during imagined shared emotional experiences.

Frontiers in psychology·2026

Same author

Papilledema and related clinical and paraclinical visual assessment in cerebral venous and sinus thrombosis versus idiopathic intracranial hypertension.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Same author

Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder.

Nature communications·2026

Same author

Intranasal oxytocin for alcohol use disorder: A systematic review and multilevel, bayesian, and variance meta-analyses of randomized clinical trial data.

Psychoneuroendocrinology·2026

Same author

Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders.

Neuroscience and biobehavioral reviews·2026

Same author

Neural correlates of mental illness related stigma: a systematic review of neuroimaging evidence.

Journal of psychiatric research·2026

Search research articles

Related Experiment Videos

Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.

Manuel Morgado¹, Sandra Rolo, Miguel Castelo-Branco

¹Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal. manuelaugustomorgado@gmail.com

International Journal of Clinical Pharmacy

|March 3, 2011

Summary

A pharmaceutical care program significantly improved medication adherence and blood pressure control in hypertensive patients. Pharmacist interventions, including education and counseling, led to better outcomes compared to standard care.

Related Experiment Videos

Area of Science:

Clinical Pharmacy
Cardiovascular Medicine
Public Health

Background:

Hypertension management is a global challenge, with poor medication adherence significantly impacting treatment efficacy.
Inadequate blood pressure control contributes to cardiovascular complications worldwide.

Purpose of the Study:

To assess the impact of a pharmaceutical care program on antihypertensive medication adherence.
To evaluate the effectiveness of pharmacist interventions in improving blood pressure control among hypertensive patients.

Main Methods:

A prospective randomized controlled trial was conducted in a Portuguese secondary care clinic.
Patients received either standard care or quarterly follow-up with a hospital pharmacist providing educational interventions and counseling.
Blood pressure and medication adherence were measured at baseline and after a 9-month intervention period.

Main Results:

The intervention group showed significantly improved blood pressure control compared to the control group (P = 0.005).
Systolic blood pressure decreased by -6.8 mmHg (P = 0.006) and diastolic blood pressure by -2.9 mmHg (P = 0.020) in the intervention group.
Medication adherence was significantly higher in the intervention group (74.5%) versus the control group (57.6%) (P = 0.012).

Conclusions:

Pharmacist-led interventions are effective in enhancing medication adherence for antihypertensive agents.
Pharmaceutical care programs can significantly improve blood pressure control in patients with hypertension.
This study highlights the crucial role of pharmacists in managing chronic diseases like hypertension.